Choice of Seizure Medication for Post-Stroke Epilepsy May Influence Survival
By Megan Brooks (Reuters Health)
|
on January 13, 2022
|
0 Comment
The researchers caution that they lacked information about all factors influencing ASM drug selection and some confounding likely occurred. Also, the findings are based only on post-stroke epilepsy patients using a single ASM and do not pertain to patients requiring drug changes for seizure control.
The study was funded by grants from the Swedish state under the ALF agreement, and grants from the Swedish Society of Medicine, the Swedish Society of Medical Research, the Linnea and Josef Carlsson Foundation, the Goteborg Medical Society, and the Magnus Bergvall Foundation. Dr. Larsson has no relevant disclosures.
Pages: 1 2 | Single Page
Related
-
Thrombolytics in Stroke: Moving Beyond Controversy to Comprehensive Care
December 7, 2024 - 0 Comment -
The Latest Research in Neurologic Emergencies
September 6, 2024 - 0 Comment -
Reader Responds: Current Status of Continuous-Seizure Management
September 2, 2024 - 0 Comment
No Responses to “Choice of Seizure Medication for Post-Stroke Epilepsy May Influence Survival”